Empire Financial Management Company, LLC
Position in RIGL — Rigel Pharmaceuticals Inc
CIK 1971875
NEW YORK, NY
Position in RIGL
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,228,832
-$2,045,307 QoQ
Shares Held
45,445
-40.6% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empire Financial Management Company, LLC holds $1,201,561 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,927 | $1,201,561 |
All Filings in RIGL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,228,832 | 45,445 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $3,274,139 | 76,445 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,535,846 | 89,511 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $440,155 | 23,500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $422,765 | 23,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $201,840 | 12,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $230,565 | 14,250 | Shares | Sole | 2024-11-18 | |
| 2024-03-31 | $450,660 | 304,500 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $279,850 | 193,000 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||